Challenge
- Build a decentralized clinical trials platform that lets participants complete entire studies digitally from home.

01 — Challenge
Traditional clinical trials require participants to travel to study sites for every survey, consent form, and follow-up. This model limits enrollment, increases dropout, and slows research. Our client, a Fortune 500 leader in clinical research, set out to build a decentralized clinical trials (DCT) platform: a system where an entire study, from eligibility screening to informed consent to years of follow-up, could be configured once and delivered to participants digitally, at home.
The technical bar was high. The platform had to serve multiple pharmaceutical sponsors on shared infrastructure, handle protected health information under strict healthcare regulations, and integrate with the systems studies actually depend on: electronic medical records, e-signature providers, telehealth, and wearable devices.
03 — The Solution
Results
Because the platform served as the base layer for other teams, performance and reliability were treated as features:
- Designed and maintained the core REST APIs consumed by the web applications and the mobile team, keeping contracts stable while the platform evolved across dozens of feature releases
- Built the conditional logic engine behind eligibility screening and surveys, supporting nested branching rules configured entirely through the study builder
- Implemented secure integration flows with third-party services (Epic EMR, DocuSign), including token handling, failure recovery, and safe processing of sensitive health data
- Systematically eliminated N+1 query patterns and optimized PostgreSQL queries across high-traffic participant and study views
- Introduced API response caching for configuration-heavy endpoints, reducing redundant load on the database
- Moved heavy operations, such as notification batches and data synchronization with the study applications, to background job queues, keeping user-facing requests fast
- Integrated cloud storage services for study assets and documents, with access controls appropriate for regulated content
- Applied lazy loading and code splitting on the frontend, and treated rendering performance as part of feature development rather than an afterthought
06 — Business Impact
The platform powered real studies for multiple top-10 global pharmaceutical sponsors, including post-marketing surveillance and observational studies run in collaboration with a major consumer technology company and its wearable devices. A single configurable platform replaced what would otherwise have been a series of one-off study applications, letting the client launch new studies in a fraction of the time.
*MakDev provides expert engineering teams for regulated, high-stakes software. Talk to us about your project.*
Start Your Project